Загрузка...
Five years of local control of subscapularis aggressive fibromatosis managed by surgery and imatinib: a case report
INTRODUCTION: Imatinib, a tyrosine kinase inhibitor, is a major therapeutic option for the management of unresectable aggressive fibromatosis. Unfortunately, for most patients of low or very low average income countries, surgery often is the first treatment option. This is related to unavailability...
Сохранить в:
| Опубликовано в: : | J Med Case Rep |
|---|---|
| Главные авторы: | , , , , , , , , |
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
BioMed Central
2014
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4307220/ https://ncbi.nlm.nih.gov/pubmed/25488584 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/1752-1947-8-416 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|